TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
TCL Archive Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division October 17, 1997
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
